"For Eye Donation please contact us"

During the past decade, Dr. Shroff's Charity Eye Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr. Shroff's Charity Eye Hospital" are "Neovascular Age-related Macular Degeneration" (1 trials), "Panuveitis" (1 trials), "Uveitis" (1 trials), "Uveitis, Anterior" (1 trials) and "Uveitis, Intermediate" (1 trials). Many other conditions were trialed in "Dr. Shroff's Charity Eye Hospital" in a lesser frequency.

Most popular intervention types in "Dr. Shroff's Charity Eye Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "4mg CLS-TA Suprachoriodal Injection" (1 trials), "LUBT010 (proposed ranibizumab biosimilar)" (1 trials), "Lucentis (ranibizumab)" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Shroff's Charity Eye Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Shroff's Charity Eye Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dr. Shroff's Charity Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Shroff's Charity Eye Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".